
Stephen Gucker
Examiner (ID: 445)
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1647, 1812, 1818, 1646, 1645 |
| Total Applications | 799 |
| Issued Applications | 370 |
| Pending Applications | 114 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5474291
[patent_doc_number] => 20090247457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'NEUROTROPHIC COMPONENTS OF THE ADNF I COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 12/197915
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 26874
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247457.pdf
[firstpage_image] =>[orig_patent_app_number] => 12197915
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/197915 | NEUROTROPHIC COMPONENTS OF THE ADNF I COMPLEX | Aug 24, 2008 | Abandoned |
Array
(
[id] => 5264358
[patent_doc_number] => 20090117043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Antibodies That Specifically Bind to Neurokinin B'
[patent_app_type] => utility
[patent_app_number] => 12/191875
[patent_app_country] => US
[patent_app_date] => 2008-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51026
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117043.pdf
[firstpage_image] =>[orig_patent_app_number] => 12191875
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/191875 | Antibodies That Specifically Bind to Neurokinin B | Aug 13, 2008 | Abandoned |
Array
(
[id] => 4618766
[patent_doc_number] => 07998480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-16
[patent_title] => 'Human BNP immunospecific antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/189232
[patent_app_country] => US
[patent_app_date] => 2008-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 35
[patent_no_of_words] => 30406
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/998/07998480.pdf
[firstpage_image] =>[orig_patent_app_number] => 12189232
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/189232 | Human BNP immunospecific antibodies | Aug 10, 2008 | Issued |
Array
(
[id] => 6443891
[patent_doc_number] => 20100144616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Neuroprotective methods and reagents'
[patent_app_type] => utility
[patent_app_number] => 12/220865
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26127
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144616.pdf
[firstpage_image] =>[orig_patent_app_number] => 12220865
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/220865 | Neuroprotective methods and reagents | Jul 27, 2008 | Abandoned |
Array
(
[id] => 6422803
[patent_doc_number] => 20100167937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Multiple forms of Alzheimer\'s disease based on differences in concentrations of protein biomarkers in blood serum'
[patent_app_type] => utility
[patent_app_number] => 12/217885
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 33886
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167937.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217885
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217885 | Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum | Jul 7, 2008 | Abandoned |
Array
(
[id] => 210538
[patent_doc_number] => 07625864
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-01
[patent_title] => 'Methods and compositions for treating ocular disorders'
[patent_app_type] => utility
[patent_app_number] => 12/164938
[patent_app_country] => US
[patent_app_date] => 2008-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3904
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/625/07625864.pdf
[firstpage_image] =>[orig_patent_app_number] => 12164938
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/164938 | Methods and compositions for treating ocular disorders | Jun 29, 2008 | Issued |
Array
(
[id] => 6395449
[patent_doc_number] => 20100178293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/665401
[patent_app_country] => US
[patent_app_date] => 2008-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2233
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20100178293.pdf
[firstpage_image] =>[orig_patent_app_number] => 12665401
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665401 | USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER'S DISEASE | Jun 9, 2008 | Abandoned |
Array
(
[id] => 4628909
[patent_doc_number] => 08007791
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Prevention and treatment of complement-associated eye conditions'
[patent_app_type] => utility
[patent_app_number] => 12/154466
[patent_app_country] => US
[patent_app_date] => 2008-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18554
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/007/08007791.pdf
[firstpage_image] =>[orig_patent_app_number] => 12154466
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/154466 | Prevention and treatment of complement-associated eye conditions | May 21, 2008 | Issued |
Array
(
[id] => 6420254
[patent_doc_number] => 20100150924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'REGULATION OF MYELINATION BY NECTIN-LIKE (NECL) MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 12/600833
[patent_app_country] => US
[patent_app_date] => 2008-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 28083
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20100150924.pdf
[firstpage_image] =>[orig_patent_app_number] => 12600833
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600833 | REGULATION OF MYELINATION BY NECTIN-LIKE (NECL) MOLECULES | May 21, 2008 | Abandoned |
Array
(
[id] => 111881
[patent_doc_number] => 07718605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Compounds for intracellular delivery of therapeutic moieties to nerve cells'
[patent_app_type] => utility
[patent_app_number] => 12/116886
[patent_app_country] => US
[patent_app_date] => 2008-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6127
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718605.pdf
[firstpage_image] =>[orig_patent_app_number] => 12116886
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/116886 | Compounds for intracellular delivery of therapeutic moieties to nerve cells | May 6, 2008 | Issued |
Array
(
[id] => 6245635
[patent_doc_number] => 20100136002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'METHODS FOR TREATING AND PREVENTING MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/598525
[patent_app_country] => US
[patent_app_date] => 2008-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16472
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136002.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598525
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598525 | Methods for treating and preventing multiple sclerosis | Apr 30, 2008 | Issued |
Array
(
[id] => 4675639
[patent_doc_number] => 20080213268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'NEUROPILIN ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/107544
[patent_app_country] => US
[patent_app_date] => 2008-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32654
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12107544
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/107544 | Neuropilin antagonists | Apr 21, 2008 | Issued |
Array
(
[id] => 6265011
[patent_doc_number] => 20100297678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'BIOMARKERS FOR MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/595597
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10537
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297678.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595597
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595597 | Biomarkers for multiple sclerosis | Apr 13, 2008 | Issued |
Array
(
[id] => 6423802
[patent_doc_number] => 20100168016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'DIAGNOSIS AND TREATMENT OF DISEASES CAUSED BY MISFOLDED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/593988
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 36628
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168016.pdf
[firstpage_image] =>[orig_patent_app_number] => 12593988
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/593988 | DIAGNOSIS AND TREATMENT OF DISEASES CAUSED BY MISFOLDED PROTEINS | Apr 10, 2008 | Abandoned |
Array
(
[id] => 4719338
[patent_doc_number] => 20080241860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'METHODS AND APPARATUS TO RECOGNIZE NERVE INJURIES'
[patent_app_type] => utility
[patent_app_number] => 12/101662
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4732
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241860.pdf
[firstpage_image] =>[orig_patent_app_number] => 12101662
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101662 | METHODS AND APPARATUS TO RECOGNIZE NERVE INJURIES | Apr 10, 2008 | Abandoned |
Array
(
[id] => 4845475
[patent_doc_number] => 20080181883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Purified Antigen for Alzheimer\'s Disease and Methods of Obtaining and Using Same'
[patent_app_type] => utility
[patent_app_number] => 12/060350
[patent_app_country] => US
[patent_app_date] => 2008-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14402
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181883.pdf
[firstpage_image] =>[orig_patent_app_number] => 12060350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/060350 | Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same | Mar 31, 2008 | Abandoned |
Array
(
[id] => 4720067
[patent_doc_number] => 20080242590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'New Method 706'
[patent_app_type] => utility
[patent_app_number] => 12/057464
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21455
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242590.pdf
[firstpage_image] =>[orig_patent_app_number] => 12057464
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/057464 | New Method 706 | Mar 27, 2008 | Abandoned |
Array
(
[id] => 4710669
[patent_doc_number] => 20080299195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 12/054334
[patent_app_country] => US
[patent_app_date] => 2008-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5970
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299195.pdf
[firstpage_image] =>[orig_patent_app_number] => 12054334
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/054334 | USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE | Mar 23, 2008 | Abandoned |
Array
(
[id] => 4740543
[patent_doc_number] => 20080234196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Treatment and prevention of vascular dementia'
[patent_app_type] => utility
[patent_app_number] => 12/072914
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 21421
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234196.pdf
[firstpage_image] =>[orig_patent_app_number] => 12072914
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/072914 | Treatment and prevention of vascular dementia | Feb 27, 2008 | Issued |
Array
(
[id] => 4728530
[patent_doc_number] => 20080208074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Methods and Systems for Characterizing and Generating a Patient-Specific Seizure Advisory System'
[patent_app_type] => utility
[patent_app_number] => 12/035335
[patent_app_country] => US
[patent_app_date] => 2008-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20390
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20080208074.pdf
[firstpage_image] =>[orig_patent_app_number] => 12035335
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/035335 | Methods and Systems for Characterizing and Generating a Patient-Specific Seizure Advisory System | Feb 20, 2008 | Abandoned |